BISPECIFIC ANTIBODIES AGAINST CD3 AND CD20 FOR TREATING CHRONIC LYMPHOCYTIC LEUKEMIA

Provided are methods of clinical treatment of chronic lymphoblastic leukemia (CLL) in human subjects using a bispecific antibody which binds to CD3 and CD20. L'invention concerne des méthodes de traitement clinique de la leucémie lymphoblastique chronique (CLL) chez des sujets humains à l'...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	AHMADI, TAHAMTAN, JURE-KUNKEL, MARIAN, BREIJ, ESTHER C.W, CHEN, JENNY J, ELLIOTT, BRIAN, CHIU, CHRISTOPHER, HIEMSTRA, IDA
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Provided are methods of clinical treatment of chronic lymphoblastic leukemia (CLL) in human subjects using a bispecific antibody which binds to CD3 and CD20. L'invention concerne des méthodes de traitement clinique de la leucémie lymphoblastique chronique (CLL) chez des sujets humains à l'aide d'un anticorps bispécifique qui se lie à CD3 et à CD20.